Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin vs Sulbactam/Ampicillin for Pulmonary Abscess and Aspiration Pneumonia
NCT01045902Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of moxifloxacin in pulmonary abscess, aspiration pneumonia, sponsored by Bayer. Started Feb 2001; status: completed.
02
Drugs
moxifloxacin
03
Conditions
pulmonary abscessaspiration pneumonia
Beyond the preview
Go deeper on NCT01045902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01045902.